PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
29.08%
Net income growth under 50% of MRVL's 326.22%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.44%
Less D&A growth vs. MRVL's 20.53%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
24.24%
Deferred tax of 24.24% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
9.43%
Less SBC growth vs. MRVL's 52.11%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-1050.00%
Negative yoy working capital usage while MRVL is 90.64%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-611.76%
Both yoy AR lines negative, with MRVL at -259.53%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-652.17%
Both reduce yoy inventory, with MRVL at -146.80%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
209.38%
AP growth well above MRVL's 2.59%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-3.57%
Negative yoy usage while MRVL is 99.19%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-166.67%
Both negative yoy, with MRVL at -68.19%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-40.45%
Negative yoy CFO while MRVL is 109.72%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
41.82%
Some CapEx rise while MRVL is negative at -55.82%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-101.71%
Both yoy lines negative, with MRVL at -29.29%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-0.14%
Both yoy lines are negative, with MRVL at -63.17%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
250.00%
Growth well above MRVL's 1.36%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-252.84%
Both yoy lines negative, with MRVL at -152.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.20%
Similar buyback growth to MRVL's 99.27%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.